Processa Pharmaceuticals (PCSA) officer adds 1,831 shares in open-market buy
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Processa Pharmaceuticals Chief Business - Strategy Officer Patrick Lin bought 1,831 shares of Common Stock in an open-market transaction at $2.22 per share. Following this purchase, he directly owns 11,007 shares and reports 1,740 shares held indirectly through the Lin Family Trust dated February 4, 2024.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 1,831 shares ($4,065)
Net Buy
2 txns
Insider
Lin Patrick
Role
Chief Business - Strategy Off
Bought
1,831 shs ($4K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 1,831 | $2.22 | $4K |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 11,007 shares (Direct, null);
Common Stock — 1,740 shares (Indirect, Lin Family Trust Feb 4, 2024)
Footnotes (1)
Key Figures
Shares purchased: 1,831 shares
Purchase price: $2.22 per share
Direct holdings after trade: 11,007 shares
+2 more
5 metrics
Shares purchased
1,831 shares
Open-market purchase of Common Stock
Purchase price
$2.22 per share
Price paid for Common Stock in code P transaction
Direct holdings after trade
11,007 shares
Common Stock directly owned following purchase
Indirect holdings
1,740 shares
Common Stock held via Lin Family Trust Feb 4, 2024
Net buy shares
1,831 shares
Net buy activity in this Form 4
Key Terms
open-market purchase, Common Stock, indirect ownership, transaction code P, +1 more
5 terms
open-market purchase financial
"transaction_action: open-market purchase"
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
Common Stock financial
"security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
indirect ownership financial
"ownership_type: indirect"
transaction code P financial
"transaction_code: P"
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
What insider transaction did Patrick Lin report for PCSA?
Patrick Lin reported an open-market purchase of 1,831 Processa Pharmaceuticals (PCSA) Common Stock shares. The transaction used code P, which indicates a purchase in the open market or a private transaction under SEC reporting rules.
What is the nature of Patrick Lin’s indirect ownership in PCSA?
Patrick Lin’s indirect ownership consists of 1,740 Processa Pharmaceuticals Common Stock shares. These shares are held through the Lin Family Trust dated February 4, 2024, and are reported as indirect (code I) beneficial ownership in the Form 4.
What does transaction code P mean in Patrick Lin’s PCSA Form 4?
Transaction code P on Patrick Lin’s Form 4 indicates a purchase in the open market or a private transaction. In this case, it corresponds to acquiring 1,831 Processa Pharmaceuticals Common Stock shares at $2.22 per share.